Items related to Drug Discovery in Cancer Epigenetics (Translational...

Drug Discovery in Cancer Epigenetics (Translational Epigenetics Series) - Hardcover

 
9780128022085: Drug Discovery in Cancer Epigenetics (Translational Epigenetics Series)

Synopsis

Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic.

  • Highlights the potential of epigenetic alterations in cancer for drug development
  • Covers the tools and methods for epigenetic drug discovery, preclinical and clinical testing, and clinical implications of epigenetic therapy
  • Provides important information regarding putative epigenetic targets, epigenetic technologies, networks and consortia for epigenetic drug discovery and routes for translation

"synopsis" may belong to another edition of this title.

About the Author

Dr. Gerda Egger is an Associate Professor of Epigenetics at the Clinical Institute of Pathology, Medical University of Vienna.

Dr. Paola Barbara Arimondo is the Director of the Unité de Service et de Recherche (USR n°3388) entitled “Epigenetic Targeting of Cancer -ETaC-“ which brings together basic and applied research - a joint laboratory of the Institut de Recherche Pierre Fabre (IRPF) and the CNRS. She is extremely experienced in researching regulatory pharmaceuticals and cancer epigenetics.

"About this title" may belong to another edition of this title.

Buy New

View this item

US$ 20.59 shipping from United Kingdom to U.S.A.

Destination, rates & speeds

Search results for Drug Discovery in Cancer Epigenetics (Translational...

Stock Image

Gerda Egger, Paola Arimondo
Published by Academic Press 2016-02-05, 2016
ISBN 10: 0128022086 ISBN 13: 9780128022085
New Hardcover

Seller: Chiron Media, Wallingford, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Hardcover. Condition: New. Seller Inventory # 6666-ELS-9780128022085

Contact seller

Buy New

US$ 138.81
Convert currency
Shipping: US$ 20.59
From United Kingdom to U.S.A.
Destination, rates & speeds

Quantity: Over 20 available

Add to basket

Stock Image

Egger, Gerda (Editor)/ Arimondo, Paola (Editor)
Published by Academic Pr, 2015
ISBN 10: 0128022086 ISBN 13: 9780128022085
New Hardcover

Seller: Revaluation Books, Exeter, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Hardcover. Condition: Brand New. 1st edition. 498 pages. 9.50x8.00x1.00 inches. In Stock. Seller Inventory # __0128022086

Contact seller

Buy New

US$ 158.57
Convert currency
Shipping: US$ 13.29
From United Kingdom to U.S.A.
Destination, rates & speeds

Quantity: 2 available

Add to basket

Seller Image

Gerda Egger
Published by ACADEMIC PR INC Dez 2015, 2015
ISBN 10: 0128022086 ISBN 13: 9780128022085
New Hardcover

Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Buch. Condition: Neu. Neuware -Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic. 498 pp. Englisch. Seller Inventory # 9780128022085

Contact seller

Buy New

US$ 179.32
Convert currency
Shipping: US$ 26.00
From Germany to U.S.A.
Destination, rates & speeds

Quantity: 1 available

Add to basket

Seller Image

Egger, Gerda|Arimondo, Paola
Published by Academic Press, 2016
ISBN 10: 0128022086 ISBN 13: 9780128022085
New Hardcover

Seller: moluna, Greven, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as bio. Seller Inventory # 151151580

Contact seller

Buy New

US$ 163.33
Convert currency
Shipping: US$ 55.38
From Germany to U.S.A.
Destination, rates & speeds

Quantity: 1 available

Add to basket